Suven Life Sciences trades higher on the bourses

19 Aug 2015 Evaluate

Suven Life Sciences is currently trading at Rs. 250.50, up by 1.40 points or 0.56% from its previous closing of Rs. 249.10 on the BSE.

The scrip opened at Rs. 250.90 and has touched a high and low of Rs. 255.90 and Rs. 245.70 respectively. So far 83635 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 338.50 on 15-Apr-2015 and a 52 week low of Rs. 121.25 on 20-Aug-2014.

Last one week high and low of the scrip stood at Rs. 264.55 and Rs. 240.00 respectively. The current market cap of the company is Rs. 3200.52 crore.

The promoters holding in the company stood at 59.44% while Institutions and Non-Institutions held 7.49% and 33.06% respectively.

Suven Life Sciences has received an approval to create an overseas subsidiary with an initial investment of $25 million for clinical development and commercialization of Suven pipeline and in-licensed molecules. The board of directors at their meeting held on August 14, 2015 has approved for the same.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

 

Suven Life Sciences Share Price

163.05 -3.00 (-1.81%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×